PHARMACEUTICAL PACKAGING MARKET ANALYSIS

Global Pharmaceutical Packaging Market, By Material (Plastic & Polymers, Aluminium Foil, Paper and Paperboard, Glass and Others), By Product Type (Plastic Bottles, Blister Packs, Caps and Closures, Pre-Fillable Syringes, Medical Specialty Bags, Pouches and Strip Packs, Pre-Filled Inhalers, Medication Tubes and Others), By End Use Industry (Pharmaceutical Manufacturing, Retail Pharmacies, Institutional Pharmacies, Contract Packaging and Others), By Livestock (Poultry, Porcine, Equine, Aquaculture, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Feb 2024
Code : CMI891
Pages :172
Formats :
Excel and PDF
Industry : Packaging

Regional Analysis

Market Regional Insights:

North America is expected to be the largest market for pharmaceutical packaging market, accounting for 39% of the market share in 2024. The market growth o in North America can be attributed to increasing demand for pharmaceutical packaging in countries such as U.S., and Canada.
Europe is estimated to account for 27% of the market share in 2024. The market growth in Europe can be attributed to increasing demand for pharmaceutical packaging in countries such as France, Germany, the Netherlands, and Russia.
Asia Pacific is estimated to account for 19% of the market share in 2024. The market growth in Asia Pacific can be attributed to increasing demand for pharmaceutical packaging in countries such as India and China.

Geographies covered:

North America: U.S. and Canada
Latin America: Brazil, Argentina, and Mexico
Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
Middle East & Africa: GCC Countries, Israel, and Rest of Middle East

North America dominates the global market owing to high pharmaceutical production and a large patient pool being treated for chronic diseases in the region. However, the fastest growth is likely to be witnessed in Asia Pacific due to increasing generic drug manufacturing, rising incomes and healthcare reforms in populous nations like India and China.